Matches in Nanopublications for { ?s ?p "[FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP108655.RAnIkhWwv5WxZRMIk4dYj7ekwO7ybNw5Ue3qy2gDa9k3Q130_assertion description "[FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP108655.RAnIkhWwv5WxZRMIk4dYj7ekwO7ybNw5Ue3qy2gDa9k3Q130_provenance.
- NP109962.RAT0L68L0yF53edKvk-HLidOAsZGyFMJq-UYVnSW60ak8130_assertion description "[FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP109962.RAT0L68L0yF53edKvk-HLidOAsZGyFMJq-UYVnSW60ak8130_provenance.
- NP113373.RA6VbSW2vd_NWS8rCI38Rc--b2JpOLhaUpmMVI7tY8Jew130_assertion description "[FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP113373.RA6VbSW2vd_NWS8rCI38Rc--b2JpOLhaUpmMVI7tY8Jew130_provenance.
- NP112235.RAObT_mKl5auynBEjJPt5fL7JL3U6QA9VR5KT76bjyYeE130_assertion description "[FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112235.RAObT_mKl5auynBEjJPt5fL7JL3U6QA9VR5KT76bjyYeE130_provenance.
- NP171869.RA14RljITkg2nmT9DoId12AMsomvPR1oQK9QPDkgnZ6bo130_assertion description "[FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171869.RA14RljITkg2nmT9DoId12AMsomvPR1oQK9QPDkgnZ6bo130_provenance.
- NP173175.RA1JRRnVZ6_0PuuB7UX4CSQnfRpyo-SinC5KrxDrafhHM130_assertion description "[FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP173175.RA1JRRnVZ6_0PuuB7UX4CSQnfRpyo-SinC5KrxDrafhHM130_provenance.
- assertion description "[FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP176580.RAFeQwGZBc2ej1DeJfX818NwmkkpfpiKHgL1_0X109p_k130_assertion description "[FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP176580.RAFeQwGZBc2ej1DeJfX818NwmkkpfpiKHgL1_0X109p_k130_provenance.
- NP243959.RARFQjFzJ51xFmixihS8flF3MIJk5qP7aLIlJk0gt1Zdo130_assertion description "[FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP243959.RARFQjFzJ51xFmixihS8flF3MIJk5qP7aLIlJk0gt1Zdo130_provenance.
- NP175444.RAqaKb7CoPc8zNLnDH46MV2VSHmO-IzkDLMqC_vBu_k4E130_assertion description "[FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP175444.RAqaKb7CoPc8zNLnDH46MV2VSHmO-IzkDLMqC_vBu_k4E130_provenance.
- NP243958.RAunM8tVMvNKSU3E8cJZnWaWglHcTH2GL0qqzVoniRfgU130_assertion description "[FGFR2 and MAP3K1 are involved in breast cancer susceptibility and confer their effects primarily in ER+ and PR+ tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP243958.RAunM8tVMvNKSU3E8cJZnWaWglHcTH2GL0qqzVoniRfgU130_provenance.